Pfizer’s Go-It-Alone Approach Nets $1.95bn COVID Vaccine Order From US Government

Supply agreement with the Health and Human Services Department and the Department of Defense reflects a profitable per dose price of $19.50 for an initial batch of 100 million doses of the vaccine candidate, pending FDA authorization or approval.

Freeway
Pfizer/BioNTech Assuming All Risk For Vaccine Development, Production

The US government’s COVID-19 vaccine purchasing agreement with Pfizer Inc. and BioNTech US is the highest such vaccine funding commitment to be announced yet, likely reflecting the fact that Pfizer is bearing all the risk for developing and manufacturing its candidate and the government does not have to.

Under an agreement announced on 22 July, the Health and Human Services Department’s Biomedical Advanced Research and Development Authority (BARDA)...

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Pricing Debate

More from Market Access